Article 22 Jan 2025 Timing Is Everything: Risks Of Delayed Patent List Submission In Canada Canada IP
Article 07 Mar 2024 Navigating Change: Advancements In Ag-Innovation And Regulation Canada Healthcare
Article 02 Jan 2024 Modernizing The Food Regulatory Framework: Updates To Food Compositional Standards And Food Additives Rules Canada Healthcare
Article 29 Jun 2023 Health Canada Increasing Oversight Of Marketed Drugs And Medical Devices Canada Healthcare
Article 21 Oct 2022 Regulatory Rules For Selling A Medical Device In Canada (Video) Canada Healthcare
Article 31 Aug 2022 Canada Modernizes Food Labelling Framework And Moves Saturated Fat, Sugars, And Sodium Front And Centre Canada Healthcare
Article 15 Aug 2022 Update On Canada's Finalized Framework For Supplemented Foods And New Labelling Rules For Natural Health Products Canada Healthcare
Article 17 Jun 2022 Gene-edited Plants Get Lighter Regulatory Touch In New Health Canada Guidance For Foods Canada Healthcare
Article 16 Jun 2022 Amendments To Canadian Patent Examination Rules Come Into Force October 3, 2022 Canada IP
Article 05 May 2022 Health Canada Updates Guidance On Switching Of A Medicinal Ingredient From Prescription Drug To Non-prescription Drug Status Canada IP
Article 04 Aug 2021 Important Changes Ahead For Regulation Of Supplemented Foods And Labelling Of Natural Health Products Canada Healthcare
Article 15 Jul 2021 Get Your Daily Dose! Regulatory Framework For Supplemented Foods And Updated Labelling For Natural Health Products Coming To Canada Canada Healthcare
Article 05 Aug 2019 Health Canada Updates Its Guidance On Promotion Of Health Products Canada Healthcare
Article 05 Jun 2019 2018 Year In Review: Top 10 Medical Device Regulatory Issues In Canada Canada Healthcare
Article 11 Apr 2019 Public Access To Clinical Information On Drugs And Medical Devices Granted Canada Healthcare
Article 08 Nov 2018 Software As Medical Devices And Digital Health In Canada: What's Next? Canada Finance
Article 04 May 2017 Government Of Canada Successful In Eli Lilly's NAFTA Challenge On The Promise Of The Patent Doctrine Canada IP